Investors

Press Releases

Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device
Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction
Endonovo Announces First Commercial Sales for SofPulse Wearable Electroceutical for Post-Operative Pain and Edema
Endonovo Therapeutics Provides Corporate Update and 2018 Outlook
Endonovo Therapeutics Engages ShareIntel, A Leader In Shareholder Intelligence Services To Investigate Market Maker and Clearing Firm Irregularities
RSS
Show All